Presentation


Live educational event (LEE):
New Frontiers in Cardiomyopathies.
Cardiomyopathies in clinical practice. International Post-Graduate Learning Course.

Scientific Area
Cardiology. Cardiomyopathies.

Course Directors
Dulce Brito, MD, Ph.D
Fausto J. Pinto, MD,P h.D

Venue
Lisbon School of Medicine, Universidade de Lisboa, Portugal

Date
28th and 29th November 2019

Educational needs
Cardiomyopathies are complex diseases. Knowledge has been growing in the last decades, in part due to the enormous advances in imaging and genetics. These conditions are expressed by varied cardiac phenotypes, sometimes overlapping or mixed, and are a frequent cause of heart failure, arrhythmias, and sudden death. Cardiomyopathies are difficult to diagnose and often have a genetic cause. Due to their complexity and heterogeneity these conditions require clinical knowledge in several medical domains. They are a cutting-edge area in terms of molecular and pathophysiological research, with some entities fitting ideal translational models. The knowledge of cardiomyopathies regarding the mechanisms involved in their development and progression is increasing, as are the diagnostic methods and new therapeutic agents able to control the natural history of these diseases, or even to prevent disease development. It is challenging to keep updated in the continuous evolution of the knowledge in this field. How to diagnose and manage, how to choose the best candidates for new or specific therapies, how to follow patients and their affected relatives, these are some of the educational needs regarding the clinical approach of patients with cardiomyopathies, which are frequently stated by cardiologists and internal medicine specialists. This LEE aims to provide up-to-date knowledge and practical training in the field.

Target audience
Medical specialists, in particular cardiologists and internal medicine specialists.

Learning objectives
After attending the Course, participants will be able to:

  • Identify a possible cardiomyopathy regarding phenotypes
  • Know the current classifications and their utility in practice
  • Apply workflows for a possible specific diagnosis, and how to proceed thereafter
  • Be aware of the role and rules of genetic testing (utility vs futility or when and why to perform, and by whom)
  • Have increased knowledge about the most common cardiomyopathies, and identify possible red-flags for a specific diagnosis
  • Diagnose, evaluate, how to follow, and current treatment options regarding patients with specific cardiomyopathies (hypertrophic sarcomeric CM, dilated CM, arrhythmogenic CM, Fabry´s, amyloidosis, non-compaction).
  • Detect and manage rare cardiomyopathies
  • Be aware of the role of myocardial biopsy
  • Gain increased knowledge regarding bench to bedside pathways in sarcomeric cardiomyopathies
  • Gain insights regarding novel therapies, including gene editing.

Course structure
Two-days course (a total of 21 hours of contact – net time), from 8:00 to 18:00 (on the 1st day) and from, 8:30 to 19:30 (on the 2nd day), plus 8 hours of study (non-presential).

Learning material (full published papers in high-standard scientific medical journals, selected by the faculty and supervised by the scientific committee) will be provided electronically to learners one month before the beginning of the course.

The course includes 14 hours of theoretical learning plus 5h of tutorials (hands-on) distributed by two days. On hands-on tutorials, learners are divided in two groups rotating by two sessions/day (each with presentation /discussion of two clinical cases with different cardiomyopathies). These interactive sessions include a total of eight different cases presentations during the course.

Sufficient time for Discussion and Q&A is programmed after each lecture and during hands-on sessions.

There will be a pre-course survey (knowledge survey of participants) on the beginning of the 1st day that will be repeated at the end of the 2nd day (post-course), to get insights regarding educational outcomes.

Learners’ attendance will be monitored by own-handwritten signature in a specific form, during each session. The hands-on sessions will be restricted to a number of eighty (80) learners. The total number of participants will be 120.
A certificate of attendance will be issued, with the number of European CME Credits obtained according to the previous evaluation by UEMS-EACCME®

Learners are expected to provide feedback on the LEE and the FML will submit to UEMS-EACCME® the event report based on the learners’ feedback.

Organizing and Scientific Committee
Carmo Fonseca, MD, Ph.D
Dulce Brito, MD, Ph.D
Fausto J. Pinto, MD, Ph.D
Inês Zimbarra Cabrita, Ph.D
Luís Rocha-Lopes, MD, Ph.D
Mónica Mendes-Pedro, MD



Organizing and Scientific Committee

Carmo Fonseca, MD, Ph.D
Dulce Brito, MD, Ph.D
Fausto Pinto, MD, Ph.D
Inês Zimbarra Cabrita, Ph.D
Luis Rocha-Lopes, MD, Ph.D
Mónica Mendes-Pedro, MD

Programme

Day 1
28th November 2019

Time Topic Speaker
Plenary Session
08:00-08:20 Welcome and Opening Session Course Directors: Fausto J. Pinto, Dulce Brito
08:20-09:00 Pre-Course survey (televote)
09:00-09:20 Overall view on Cardiomyopathies: the pathway from phenotype to a diagnosis Dulce Brito
09:20-09:40 Genetic testing: role and rules Luis Rocha-Lopes
09:40-10:00 Q&A Chair: Dulce Brito
Panelists: Luis Rocha-Lopes, Lorenzo Monserrat, Oana Moldovan, Carmo Fonseca.
10:00-10:20 Break
Sarcomeric hypertrophic cardiomyopathy: how to diagnose and manage
10:20-10:40 Clinical presentation, imaging, and pitfalls. Nuno Cardim
10:40-11:00 The patient and the family. Risk stratification and Recommendations. Lorenzo Monserrat  
11:00-11:20 When and how to treat. Current options and prospects. António Freitas
11:20-11:40 Q&A Chair: Nuno Cardim
Panelists: Lorenzo Monserrat, Luis Rocha-Lopes, Dulce Brito, António Freitas, Inês Cabrita
Plenary Session
Approach to  dilated cardiomyopathies
11:40-12:00 Current classification and the roadmap to aetiology Carolina Negrier
12:00-12:20 Genetic disease: the importance of genotypes for treatment decisions Elisabete Martins  
12:20-12:40 The role of myocardial biopsy Oliver Guttmann
12:40-13:00 Current recommended therapies: one-fits all? Cândida Fonseca
13:00-13:20 Q&A Chair: Elisabete Martins
Panelists: Carolina Negrier, Oliver Guttmann, Cândida Fonseca, Ana G. Almeida
13:20-14:30 Lunch
14:30-15:00 Sarcomeric cardiomyopathies: pathways from bench to bedside. Carmo Fonseca
Hands-on tutorials
  Room 7 (Group A) Room 8 (Group B)
15:00-15:40 Clinical Vignette 1 Clinical Vignette 3
  Presenters/Trainers: Luis Lopes/Inês Cruz Presenters/Trainers: Carolina Negrier /Ana Rita Almeida
  Live Discussion/Q&A Live Discussion/Q&A
15:40-16:20 Clinical Vignette 2 Clinical Vignette 4
  Presenters/Trainer:s Nuno Cardim/Alexandra Toste Presenters/Trainers: Elisabete Martins/Alexandra Sousa
  Live Discussion/Q&A Live Discussion/Q&A
16:20-16:30 Break
Room 7 (Group A) Room 8 (Group B)  
16:30-17:10 Clinical Vignette 3 Clinical Vignette 1
  Presenters/Trainers: Carolina Negrier/Ana Rita Almeida Presenters/Trainers: Luis Lopes/Inês Cruz
  Live Discussion/Q&A Live Discussion/Q&A
17:10-17:50 Clinical Vignette 4 Clinical Vignette 2
  Presenters/Trainers: Elisabete Martins/Alexandra Sousa Presenters/Trainers: Nuno Cardim/Alexandra Toste
  Live Discussion/Q&A Live Discussion/Q&A
Plenary Session
17:50-18:00 Closing Summary of Day 1 Dulce Brito, Fausto J. Pinto

 

Day 2
29th November 2019

Time Topic Speaker
Plenary Session
Fabry´s disease
08:30-09:00 Disease Overview Patrício Aguiar
09:00-09:30 Cardiac phenotypes: · Early and late red flags · Workflow for diagnosis · Disease monitoring Christoph Kampmann
09:30-10:00 Treatment options: · Which, for whom, and when · Expected outcomes Maurizio Pieroni  
10:00-10:20 Q&A Chair: Christoph Kampmann
Panelists: Maurizio Pieroni, Patrício Aguiar, Olga Azevedo, João Abecasis
10:20-10:35 Break
Amyloid heart disease
10:35-10:55 An old disease revisited: what has changed? Pablo Garcia-Pavia
10:55-11:15 The heart in amyloidosis: old red flags, new imaging tools Nuno Marques
11:15-11:35 The pathways for a correct diagnosis and amyloid characterization Claudio Rapezzi
11:35-11:55 Managing  amyloid CM Rui Baptista
11:55-12:15 Q&A Chair: Claudio Rapezzi
Panelists: Pablo Garcia-Pavia Nuno Marques, Rui Baptista, Dulce Brito, Mónica Pedro, João Abecasis
Arrhythmogenic cardiomyopathy: up-to-date
12:20-12:40 Characterization and classification Luis Rocha Lopes
12:40-13:00 Risk evaluation and management Juan Jimenez-Jaimez
13:00-13:20 Q&A Chair: Luis Rocha Lopes
Panelists: Juan Jimenez-Jaimez, Nuno Cortez Dias, António Freitas, João Abecasis
13:20-14:30 Lunch  
Plenary Session
14:30-15:00

Rare cardiomyopathies

Mónica Mendes-Pedro & Emanuel Correia
15:00-15:10

Q&A

Chair: Monica Mendes-Pedro
Panelists: Luis Rocha Lopes, Emanuel Correia, Rui Plácido, Inês Cabrita
Hands-On Tutorials
  Room 7 (Group A) Room 8 (Group B)
15:20-16:00 Clinical Vignette 1 Clinical Vignette 3
  Presenters/Trainers: Mónica Mendes Pedro/Conceição Trigo-Pereira Presenters/Trainers: Rui Baptista/Emanuel Correia
  Live Discussion/Q&A Live Discussion/Q&A
16:00-16:40 Clinical Vignette 2 Clinical Vignette 4
  Presenters/Trainers: Patrício Aguiar/Olga Azevedo Presenters/Trainers Nuno Marques/Dina Bento
  Live Discussion/Q&A Live Discussion/Q&A
16:40-16:50 Break
  Room 7 (Group A) Room 8 (Group B)
16:50-17:30 Clinical Vignette 3 Clinical Vignette 1
  Presenters/Trainers: Rui Baptista/Emanuel Correia Presenters/Trainers: Mónica Mendes Pedro/ Conceição Trigo-Pereira
  Live Discussion/Q&A Live Discussion/Q&A
     
17:30-18:10 Clinical Vignette 4 Clinical Vignette 2
  Presenters/Trainers: Nuno Marques/Dina Bento Presenters/Trainers: Patrício Aguiar/Olga Azevedo
  Live Discussion/Q&A Live Discussion/Q&A
Plenary Session
18:10-18:40 New advances in diagnosis and management of paediatric cardiomyopathies  Juan Pablo Kaski
18:40-19:20 Post-Course survey (televote) Dulce Brito, Mónica Pedro
Fausto Pinto
19:20-19:30 Closing Summary of Day 2



Accreditation

eaccme

This event has been accredited by the EACCME® - European Accreditation Council for Continuing Medical Education .

Faculty

Abecasis, João
Aguiar, Patrício
Almeida, Ana G.
Almeida, Ana Rita
Azevedo, Olga
Baptista, Rui
Bento, Dina
Brito, Dulce
Cabrita, Inês
Cardim, Nuno
Correia, Emanuel
Cortez-Dias, Nuno
Cruz, Inês
Fonseca, Cândida
Fonseca, Carmo
Freitas, António
Garcia-Pavia, Pablo
Guttmann , Oliver
Jimenez-Jaimez, Juan
Kampmann, Christoph
Kaski, Juan
Marques, Nuno
Martins, Elisabeth
Moldovan, Oana
Mendes-Pedro, Mónica
Monserrat, Lorenzo
Negrier, Carolina
Pieroni, Mauricio
Pinto, Fausto J.
Plácido, Rui
Rappezzi , Claudio
Rocha-Lopes, Luis
Sousa, Alexandra
Toste, Alexandra
Trigo-Pereira, Conceição

REGISTRATION

Course Price:
€350*
€500 registration fee

Click here for online registration

*early registration fee (valid until the end of September)